What are the best practices for aligning market access teams across different regions and countries?
Market access is a critical function in the pharmaceutical and biotechnology industry, as it involves developing and executing strategies to ensure that patients can access and afford innovative therapies. However, market access is also a complex and dynamic process that requires coordination and alignment across different regions and countries, each with their own regulatory, reimbursement, and stakeholder environments. In this article, we will explore some of the best practices for aligning market access teams across different regions and countries, and how to overcome some of the common challenges and barriers.